Paul Tudor Jones Medical Devices

Tudor Investment Corp Et Al

$25.1 Billion
Q4 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade
NARI Inari Medical, Inc.	$4.27B	$9.72 Million 0.04% of portfolio	190,405	Q4 2024 Added 1,327.54%
MDT Medtronic PLC	$120B	$8.78 Million 0.03% of portfolio	109,925	Q4 2024 New
GMED Globus Medical Inc	$6.16B	$8.77 Million 0.03% of portfolio	106,020	Q4 2024 Reduced 36.01%
SYK Stryker Corp	$148B	$6.77 Million 0.03% of portfolio	18,795	Q4 2024 Added 276.05%
LIVN Liva Nova PLC	$2.22B	$6.31 Million 0.03% of portfolio	136,345	Q4 2024 Reduced 14.11%
TNDM Tandem Diabetes Care Inc	$2.16B	$6.09 Million 0.02% of portfolio	169,043	Q4 2024 Added 314.84%
ATEC Alphatec Holdings, Inc.	$1.16B	$5.38 Million 0.02% of portfolio	585,865	Q4 2024 Added 295.39%
AORT Artivion, Inc.	$1.03B	$5.1 Million 0.02% of portfolio	177,062	Q4 2024 Added 22.99%
IART Integra Lifesciences Holdings Corp	$1.97B	$4.72 Million 0.02% of portfolio	208,075	Q4 2024 Reduced 23.34%
BFLY Butterfly Network, Inc.	$687M	$2.76 Million 0.01% of portfolio	884,925	Q4 2024 New
BIO Bio Rad Laboratories, Inc.	$6.8B	$2.44 Million 0.01% of portfolio	7,433	Q4 2024 New
RXST Rx Sight, Inc.	$801M	$2.34 Million 0.01% of portfolio	68,138	Q4 2024 Added 116.52%
OFIX Orthofix Medical Inc.	$345M	$2.33 Million 0.01% of portfolio	133,530	Q4 2024 Added 0.2%
BVS Bioventus Inc.	$632M	$2.22 Million 0.01% of portfolio	211,304	Q4 2024 Reduced 17.82%
IRMD Iradimed Corp	$700M	$1.71 Million 0.01% of portfolio	31,016	Q4 2024 Added 35.62%
TMCI Treace Medical Concepts, Inc.	$537M	$1.62 Million 0.01% of portfolio	217,687	Q4 2024 Added 16.35%
KIDS Orthopediatrics Corp	$527M	$1.54 Million 0.01% of portfolio	66,486	Q4 2024 Added 177.49%
AXGN Axogen, Inc.	$823M	$1.44 Million 0.01% of portfolio	87,551	Q4 2024 Reduced 22.07%
ZIMV Zim Vie Inc.	$344M	$1.37 Million 0.01% of portfolio	97,536	Q4 2024 Added 0.2%
SIBN Si Bone, Inc.	$623M	$1.25 Million 0.0% of portfolio	89,031	Q4 2024 Reduced 20.78%
LUNG Pulmonx Corp	$344M	$1.01 Million 0.0% of portfolio	149,102	Q4 2024 Added 8.98%
CVRX Cv Rx, Inc.	$283M	$961,000 0.0% of portfolio	75,885	Q4 2024 Added 19.54%
INGN Inogen Inc	$185M	$759,000 0.0% of portfolio	82,852	Q4 2024 Added 44.92%
VREX Varex Imaging Corp	$530M	$706,000 0.0% of portfolio	48,452	Q4 2024 New
ANIK Anika Therapeutics, Inc.	$258M	$592,000 0.0% of portfolio	35,989	Q4 2024 Added 22.65%
FNA Paragon 28, Inc.	$998M	$559,000 0.0% of portfolio	54,204	Q4 2024 New
AVNS Avanos Medical, Inc.	$726M	$518,000 0.0% of portfolio	32,571	Q4 2024 New
NVRO Nevro Corp	$203M	$484,000 0.0% of portfolio	130,121	Q4 2024 Reduced 0.03%
ARAY Accuray Inc	$192M	$214,000 0.0% of portfolio	108,362	Q4 2024 Reduced 64.09%
OM Outset Medical, Inc.	$36.5M	$200,000 0.0% of portfolio	180,444	Q3 2024 Reduced 0.08%
SENS Senseonics Holdings, Inc.	$410M	$90,000 0.0% of portfolio	174,383	Q4 2022 Reduced 3.82%

Shares Options

Paul Tudor Jones

Paul Tudor Jones is the founder and CEO of Tudor Investment Corp, a successful investment firm that focuses on macro investing. Jones is known for his expertise in macro investing and his innovative approach to investing. He has generated strong returns for his clients over the long term.

Track Paul Tudor Jones's portfolio

Track Paul Tudor Jones's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Account